PFNLive
Mylan Tries Snatching Ranbaxy's Rights to Novartis Blockbuster
Published: Friday, December 7th 2012
(Fierce) - Generic drugmaker Mylan ($MYL), impatient that money is sitting on the table, has sued the FDA to try to snatch the rights to produce a generic of Novartis' ($NVS) blockbuster blood pressure med, Diovan.

Comment(s)
Your comments are valuable to us. Thank you.
*Required
*Name
*Email Address
Body
Related Articles
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.